ZYVERSA THERAPEUTICS, INC. Cash and Cash Equivalents
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Cash and Cash Equivalents of $213.56 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2022-11-14
- 2022-09-30: Cash and Cash Equivalents, at Carrying Value $213.56K.
- 2022-06-30: Cash and Cash Equivalents, at Carrying Value $340.04K.
- 2022-03-31: Cash and Cash Equivalents, at Carrying Value $830.22K.
- 2021-12-31: Cash and Cash Equivalents, at Carrying Value $928.39K.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2022-09-30 | $213.56K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $340.04K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $830.22K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $928.39K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |